PMC:7195088 / 6269-6453 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"193","span":{"begin":40,"end":51},"obj":"Chemical"},{"id":"194","span":{"begin":56,"end":66},"obj":"Chemical"}],"attributes":[{"id":"A193","pred":"tao:has_database_id","subj":"193","obj":"MESH:C462182"},{"id":"A194","pred":"tao:has_database_id","subj":"194","obj":"MESH:C086979"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Pending high-level supporting evidence, favipiravir and umifenovir should not be provided an outside RCT, at least in those countries where they are not approved for other indications."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T22","span":{"begin":40,"end":51},"obj":"Chemical"},{"id":"T23","span":{"begin":56,"end":66},"obj":"Chemical"}],"attributes":[{"id":"A22","pred":"chebi_id","subj":"T22","obj":"http://purl.obolibrary.org/obo/CHEBI_134722"},{"id":"A23","pred":"chebi_id","subj":"T23","obj":"http://purl.obolibrary.org/obo/CHEBI_134730"}],"text":"Pending high-level supporting evidence, favipiravir and umifenovir should not be provided an outside RCT, at least in those countries where they are not approved for other indications."}

{"project":"LitCovid-sentences","denotations":[{"id":"T44","span":{"begin":0,"end":184},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Pending high-level supporting evidence, favipiravir and umifenovir should not be provided an outside RCT, at least in those countries where they are not approved for other indications."}